Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Zur Ergebnisliste
Ergebnis 6 von 71
    Datensatz exportieren als...
  • BibTeX
Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation
Annals of hematology, 2013-01, Vol.92 (1), p.125-127
2013

Details

Autor(en) / Beteiligte
Titel
Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation
Ist Teil von
  • Annals of hematology, 2013-01, Vol.92 (1), p.125-127
Ort / Verlag
Berlin/Heidelberg: Springer-Verlag
Erscheinungsjahr
2013
Link zum Volltext
Quelle
SpringerLink (Online service)
Sprache
Englisch
Identifikatoren
ISSN: 0939-5555
eISSN: 1432-0584
DOI: 10.1007/s00277-012-1524-0
Titel-ID: cdi_proquest_journals_1314390521
Format
–
Schlagworte
Adult, Antineoplastic Combined Chemotherapy Protocols - administration & dosage, Antineoplastic Combined Chemotherapy Protocols - therapeutic use, Carmustine - administration & dosage, Cisplatin - administration & dosage, Combined Modality Therapy, Compassionate Use Trials, Cyclophosphamide - administration & dosage, Cytarabine - administration & dosage, Dexamethasone - administration & dosage, Doxorubicin - administration & dosage, Etoposide - administration & dosage, Hematology, Humans, Immunoconjugates - therapeutic use, Letter to the Editor, Lymphocyte Transfusion, Lymphoma, Large-Cell, Anaplastic - complications, Lymphoma, Large-Cell, Anaplastic - drug therapy, Lymphoma, Large-Cell, Anaplastic - enzymology, Lymphoma, Large-Cell, Anaplastic - surgery, Male, Medicine, Medicine & Public Health, Melphalan - administration & dosage, Molecular Targeted Therapy, Neoplasm Proteins - analysis, Neoplasm Proteins - antagonists & inhibitors, Oncology, Peripheral Blood Stem Cell Transplantation, Prednisone - administration & dosage, Protein Kinase Inhibitors - therapeutic use, Pyrazoles - therapeutic use, Pyridines - therapeutic use, Receptor Protein-Tyrosine Kinases - analysis, Receptor Protein-Tyrosine Kinases - antagonists & inhibitors, Remission Induction, Respiration, Artificial, Respiratory Insufficiency - etiology, Respiratory Insufficiency - therapy, Transplantation, Homologous, Vincristine - administration & dosage

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX